These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 9116702)
1. Induction of anticardiolipin antibody and/or lupus anticoagulant in rabbits by immunization with lipoteichoic acid, lipopolysaccharide and lipid A. Gotoh M; Matsuda J Lupus; 1996 Dec; 5(6):593-7. PubMed ID: 9116702 [TBL] [Abstract][Full Text] [Related]
2. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
4. Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I. Keeling DM; Wilson AJ; Mackie IJ; Isenberg DA; Machin SJ J Clin Pathol; 1993 Jul; 46(7):665-7. PubMed ID: 8157757 [TBL] [Abstract][Full Text] [Related]
5. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to lipid A, lipopolysaccharide and lipoteichoic acid in systemic lupus erythematosus patients with antiphospholipid antibodies. Gotoh M; Matsuda J Lupus; 1997; 6(8):678-9. PubMed ID: 9364428 [No Abstract] [Full Text] [Related]
7. Some plasmin-induced antibodies bind to cardiolipin, display lupus anticoagulant activity and induce fetal loss in mice. Chen XX; Gu YY; Li SJ; Qian J; Hwang KK; Chen PP; Chen SL; Yang CD J Immunol; 2007 Apr; 178(8):5351-6. PubMed ID: 17404320 [TBL] [Abstract][Full Text] [Related]
8. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
9. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [TBL] [Abstract][Full Text] [Related]
10. Anti beta 2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance. Ogasawara M; Aoki K; Matsuura E; Sasa H; Yagami Y Lupus; 1996 Dec; 5(6):587-92. PubMed ID: 9116701 [TBL] [Abstract][Full Text] [Related]
11. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort. Petri M Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980 [TBL] [Abstract][Full Text] [Related]
12. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792 [TBL] [Abstract][Full Text] [Related]
13. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance]. Wisløff F; Sletnes KE; Schjetlein R Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2269-72. PubMed ID: 8362396 [TBL] [Abstract][Full Text] [Related]
14. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies. Zhu M; Olee T; Le DT; Roubey RA; Hahn BH; Woods VL; Chen PP Br J Haematol; 1999 Apr; 105(1):102-9. PubMed ID: 10233371 [TBL] [Abstract][Full Text] [Related]
16. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Avcin T; Ambrozic A; Bozic B; Accetto M; Kveder T; Rozman' B Clin Exp Rheumatol; 2002; 20(1):101-8. PubMed ID: 11892692 [TBL] [Abstract][Full Text] [Related]
17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
18. Crossreactivity of anti-cardiolipin antibodies with glycolipids and endothelial cells. Kaise S; Watanabe H; Kasukawa R Fukushima J Med Sci; 1994 Jun; 40(1):25-37. PubMed ID: 7988982 [TBL] [Abstract][Full Text] [Related]
19. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies]. Matsuura E Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876 [TBL] [Abstract][Full Text] [Related]
20. Laboratory tests for the antiphospholipid syndrome. Pericleous C; Ripoll VM; Giles I; Ioannou Y Methods Mol Biol; 2014; 1134():221-35. PubMed ID: 24497366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]